Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rami Burstein

Showing results (141-150 of 166) with videos related to

Pageof 17
Sort By:
Frontiers in Human Neuroscience|April 11, 2019
Migraine in the Young Brain: Adolescents vs. Young AdultsElisabeth Colon, Allison Ludwick, Sophie L Wilcox, et al.
Cephalalgia : an International Journal of Headache|August 28, 2024
Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to actionMario Fernando Prieto Peres, Simona Sacco, Patricia Pozo-Rosich, et al.
Cephalalgia : an International Journal of Headache|September 26, 2025
OnabotulinumtoxinA alters pro- and anti-inflammatory dural macrophage response to CSD in female miceAaron J Schain, Diego Delgado Fajardo, Andrew M Strassman, et al.
Cephalalgia : an International Journal of Headache|May 1, 2020
Dizziness and vertigo during the prodromal phase and headache phase of migraine: A systematic review and meta-analysisAfrim Iljazi, Håkan Ashina, Richard B Lipton, et al.
Nature Reviews. Disease Primers|January 14, 2022
MigraineMichel D Ferrari, Peter J Goadsby, Rami Burstein, et al.
Neurology|August 17, 2022
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe PainRichard B Lipton, David W Dodick, Peter J Goadsby, et al.
The Lancet. Neurology|October 4, 2015
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b studyMarcelo E Bigal, David W Dodick, Alan M Rapoport, et al.
Pain|June 16, 2018
Color-selective photophobia in ictal vs interictal migraineurs and in healthy controlsRony-Reuven Nir, Alice J Lee, Shaelah Huntington, et al.
Frontiers in Human Neuroscience|October 22, 2016
Brain Changes in Responders vs. Non-Responders in Chronic Migraine: Markers of Disease ReversalCatherine S Hubbard, Lino Becerra, Jonathan H Smith, et al.
Pain|October 31, 2018
The migraine eye: distinct rod-driven retinal pathways' response to dim light challenges the visual cortex hyperexcitability theoryCarolyn A Bernstein, Rony-Reuven Nir, Rodrigo Noseda, et al.
Pageof 17

Showing results (141-150 of 166) with videos related to

Sort By:
Pageof 17
Frontiers in Human Neuroscience|April 11, 2019
Migraine in the Young Brain: Adolescents vs. Young AdultsElisabeth Colon, Allison Ludwick, Sophie L Wilcox, et al.
Cephalalgia : an International Journal of Headache|August 28, 2024
Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to actionMario Fernando Prieto Peres, Simona Sacco, Patricia Pozo-Rosich, et al.
Cephalalgia : an International Journal of Headache|September 26, 2025
OnabotulinumtoxinA alters pro- and anti-inflammatory dural macrophage response to CSD in female miceAaron J Schain, Diego Delgado Fajardo, Andrew M Strassman, et al.
Cephalalgia : an International Journal of Headache|May 1, 2020
Dizziness and vertigo during the prodromal phase and headache phase of migraine: A systematic review and meta-analysisAfrim Iljazi, Håkan Ashina, Richard B Lipton, et al.
Nature Reviews. Disease Primers|January 14, 2022
MigraineMichel D Ferrari, Peter J Goadsby, Rami Burstein, et al.
Neurology|August 17, 2022
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe PainRichard B Lipton, David W Dodick, Peter J Goadsby, et al.
The Lancet. Neurology|October 4, 2015
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b studyMarcelo E Bigal, David W Dodick, Alan M Rapoport, et al.
Pain|June 16, 2018
Color-selective photophobia in ictal vs interictal migraineurs and in healthy controlsRony-Reuven Nir, Alice J Lee, Shaelah Huntington, et al.
Frontiers in Human Neuroscience|October 22, 2016
Brain Changes in Responders vs. Non-Responders in Chronic Migraine: Markers of Disease ReversalCatherine S Hubbard, Lino Becerra, Jonathan H Smith, et al.
Pain|October 31, 2018
The migraine eye: distinct rod-driven retinal pathways' response to dim light challenges the visual cortex hyperexcitability theoryCarolyn A Bernstein, Rony-Reuven Nir, Rodrigo Noseda, et al.
Pageof 17